Novo Nordisk A/S has announced a share repurchase program initiated on May 6, 2024, with a total repurchase amount of up to DKK 2.2 billion from May 7 to August 5, 2024. As of July 5, 2024, a total of 10,246,595 B shares have been repurchased at an average price of DKK 875.46 per share.